Strategic Growth Target diagnostics expansion into multiplex infectious disease panels in healthcare networks and laboratories, leveraging Great Basin Scientific's Bordetella and Staph ID/R capabilities to expand product adoption in acute care settings.

Technology Advantage Position GBSci's chip-based, sample-to-result platform as a cost-effective, fast solution for rapid pathogen identification, appealing to hospitals, clinics, and reference labs seeking competitive TCO reductions.

Geographic Expansion Leverage existing U.S. and European CE Marked products to pursue new geographies and hospital systems, offering a streamlined regulatory pathway for faster market entry and multi-country contracts.

Revenue Levers Explore tiered pricing, volume discounts, and bundled panels to boost adoption among mid-to-large sized healthcare providers, labs, and managed care organizations seeking value-driven diagnostics.

Funding Spotlight Highlight the company’s substantial funding runway to potential strategic partners or customers, underscoring stability and capability to support long-term procurement commitments and joint development projects.